Isala and Elekta sign long-term partnership agreement for optimal cancer care
ZWOLLE NL — Tuesday, June 27, 2017
Isala and Elekta (EKTA-B.ST) signed a 15-year partnership agreement to implement the latest developments in oncology and radiotherapy at Isala.
Next to upgrading existing equipment the agreement also includes several Versa HD™ linear accelerators, a Leksell Gamma Knife® Icon™ radiosurgery system, MOSAIQ® workflow software and a managed services contract.
Elekta and Isala today also announced the start of a long-term technology partnership for radiotherapy and oncology. In signing the agreement, Isala and Elekta have further enforced their continuing commitment to bringing the best possible cancer care to Dutch patients.
Gabriël Paardekooper, MD, radiation oncologist and chairman of the radiotherapy department at Isala commented, “The technology partnership with a proven, dependable collaborator like Elekta will help us further our oncology vision. With the upgrade of our existing linear accelerators, we will not only ensure that we can offer our patients state-of-the-art treatment, but we will also optimize our workflow, since all devices will be equipped with identical specifications to increase flexibility and capacity. Further, installing a Leksell Gamma Knife will enable us to provide patients with brain cancer and complex neurological disorders with the most precise technology available.”